Condition
UTUC clinical trials and research
As of November 12, 2026, Find a Trial lists 6 UTUC clinical trials that are recruiting, at sites in 2 countries (most in China (5), Israel (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest UTUC clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Urine test to detect urological cancers in people with blood in urine | — | Shanghai | Recruiting | Sep 10, 2026 |
| Trastuzumab Rezetecan and Gemcitabine before surgery for HER2-positive UTUC | Phase 2 | Huanggang, Hubei and 9 other locations | Recruiting | Aug 3, 2026 |
| Non-invasive urine test to screen for urothelial cancer in adults with blood in urine | — | Zhengzhou, Henan | Recruiting | May 29, 2026 |
| Monitoring recurrence of urothelial carcinoma using urinary tests | — | Beijing, Beijing Municipality | Recruiting | May 28, 2025 |
| Single chemotherapy instillation after ureteroscopy for UTUC | — | Ashdod and 9 other locations | Recruiting | Dec 12, 2023 |
| Combination treatment for HER2-positive upper tract urothelial carcinoma after surgery | Phase 2 | Nanjing, Jiangsu | Recruiting | Jun 23, 2023 |
All recruiting trials (6)
-
Urine test to detect urological cancers in people with blood in urine
This study tests whether a urine fluorescence test can help find urological cancers in adults with hematuria before biopsy.
-
Trastuzumab Rezetecan and Gemcitabine before surgery for HER2-positive UTUC
This study tests whether giving trastuzumab deruxtecan with gemcitabine before and around surgery can improve outcomes for people with HER2-positive upper tract urothelial cancer.
-
Non-invasive urine test to screen for urothelial cancer in adults with blood in urine
A noninvasive urine test is being used to see if it can correctly identify urothelial cancer in adults who have blood in urine and a suspicious imaging finding.
-
Monitoring recurrence of urothelial carcinoma using urinary tests
This study is testing if urine tests can help track the return of urothelial carcinoma in patients with different types of bladder and kidney cancer.
-
Single chemotherapy instillation after ureteroscopy for UTUC
This study is testing if a single dose of chemotherapy given after a ureteroscopy can help prevent bladder cancer from coming back in people with upper tract urothelial carcinoma.
-
Combination treatment for HER2-positive upper tract urothelial carcinoma after surgery
This study is testing a new combination of targeted therapy and immune treatment to see if it helps prevent cancer from coming back in patients with HER2-positive upper tract urothelial carcinoma after surgery.
Related topics
Quick answers
How many UTUC clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (5 trials), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.